Sweet dreams? gummy supplement put to the test for better sleep

NCT ID NCT07781332

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 24, 2026 · Last updated Aug 25, 2026 · Updated 1 time

Summary

This trial tests whether a daily sleep gummy can improve sleep quality and quantity in adults aged 20-50 who have self-reported sleep issues. Participants take one gummy before bed for 7 days while wearing a Fitbit tracker to measure sleep patterns. The study compares sleep metrics like time to fall asleep, deep sleep, and grogginess against baseline to see if the supplement makes a difference.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
FlavCity Sleep Gummy (dietary supplement)
What this could lead to
If effective, this gummy could offer a simple, over-the-counter option to help people fall asleep faster and enjoy deeper, more restful sleep.
What could go wrong
This is a small, short-term study without a placebo group, so results may not prove the gummy works better than no treatment. Individual responses can vary, and the supplement is not a cure for chronic sleep disorders.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

40 people

The number who actually took part.

Started

Sep 2023

Finished

Sep 2023

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 50 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male or female * 20-50 years old * Self-reported issues with sleep * Willing to discontinue any over-the-counter medications, prescription medications, and herbal supplements used to assist with sleep * Willing to maintain their standard sleep pattern and activity level for the duration of the study * Be generally healthy and not living with any uncontrolled chronic disease Exclusion Criteria: * Diagnosed with any chronic sleep condition including insomnia, narcolepsy, or sleep apnea * Vegan participants (as this product contains beeswax which is not suitable for participants on a vegan diet) * Women who are pregnant, breastfeeding, or trying to conceive (TTC) * Anyone unwilling or unable to follow the study protocol * Any pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders * Has undergone in the last three weeks, is currently undergoing, or planning to undergo any significant medical procedures in the next three weeks * A history of severe allergic reactions including but not limited to any of the product's ingredients * Anyone who is a heavy drinker (a woman who drinks 8 or more alcoholic drinks per week or a man who drinks 15 or more alcoholic drinks per week) * Individuals taking prescription or over-the-counter medication that affects sleep * Use of any herbal remedies which can affect sleep * Has a job that disrupts nighttime sleep (e.g., third shift or night shift work) * Anyone who is using illicit drugs

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Insomnia (self-reported, non-diagnosed) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Citruslabs

    Las Vegas, Nevada, 89101, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.